ibd precision therapy
Chronic Disease Management: 57% Faster JAK vs Biologic?
New JAK inhibitors reduce Crohn's disease flare-ups by 57% compared with placebo, delivering faster symptom control and significant cost savings. This breakthrough builds on a wave of precision therapies that target specific immune pathways rather than blanket immunosuppression. The phase-3 U-STEP trial, which enrolled 642 patients across North